September 6, 2017, WINOOSKI VT, USA — BioTek proudly announces its donation of $25,000 towards the construction of the Science, Technology, Engineering and Mathematics (STEM) Complex at The University ...

Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis BioTek is a recognized leader for plate ...

BioTek Instruments will be recognized as a 2017 Vermont Business Growth Award winner at a ceremony to be held September 12, 2017 at The Sheraton Hotel & Conference Center, in Burlington, VT. This ...

BioTek Instruments is pleased to announce its collaboration with MilliporeSigma on an integrated solution for long-term live cell experiments and dynamic time-lapse analyses, including automated cell ...

Agilent Technologies Inc. recently announced it had signed an agreement to acquire BioTek Instruments, a global leader in life science instrumentation. BioTek design, manufacture and distribute a wide ...

BioTek Instruments announced its sale for $1.165 billion to a California company Thursday, joining a rare club of Vermont companies to command 10-figure prices. "It's been a great day and a busy day," ...

Since the onset of the current pandemic, COVID-19 has been described largely as a respiratory disease. While the respiratory tract and alveoli are one of the primary sites of infection and pathology, ...

Agilent Technologies, Inc. A has entered into a definitive agreement to acquire Winooski, VT-based BioTek Instruments, Inc., a provider of life science instrumentation, in a bid to expand presence in ...

Seven Ways Seven Days Gets You Through the Week: Trustworthy local reporting. Piping‑hot food news. Thoughtful obituaries. Must‑do events. Stuck in Vermont videos. Eye‑opening personals. All the fun ...

BioTek Instruments announces enhancements to the MultiFlo™ FX Multi-Mode Dispenser to facilitate cell biology workflows. MultiFlo FX has a modular design that makes it easy for users to add ...

Agilent (NYSE: A) will acquire BioTek Instruments in a $1.165 billion deal. The transaction is expected to be completed in Agilent’s fiscal fourth quarter. BioTek designs, manufactures and distributes ...